Fda Dietary Supplement Innovation

Remarks by norman sharpless m d.
Fda dietary supplement innovation. Public meeting is may 16 2019 8 30 am 4 00 pm at fda in college park md. The fda announced the public meeting on april 11 2019 via a federal register notice in which fda sought comments from interested parties to help the agency facilitate responsible innovation in the dietary supplement industry while preserving and strengthening fda s ability to efficiently and effectively protect the public from unsafe and. The american medical association has issued a new policy on dietary supplements that calls for more enforcement from fda labeling changes and other measures.
Statement from fda commissioner scott gottlieb m d on the agency s new efforts to strengthen regulation of dietary supplements by modernizing and reforming fda s oversight. To contact the office of dietary supplement programs email. Once a dietary supplement is on the market fda has certain safety monitoring responsibilities.
When the dietary supplement health and education act dshea was passed back in 1994 it came with a new dietary ingredient ndi provision requiring the fda to be notified at least. Industry stakeholders found points of. These include monitoring mandatory reporting of serious adverse events by dietary supplement firms.
The food and drug administration fda held a public meeting entitled responsible innovation in dietary supplements. Acting commissioner at the fda public meeting on responsible innovation in dietary supplements may 16 2019 fda cfsan college park campus. The food and drug administration fda has announced plans to drastically alter the way dietary supplements are regulated and your help is needed to protect the industry from this attempted government takeover.
Office of dietary supplement programs hfs 810 food and drug administration 5001 campus dr college park md 20740.